82 results
8-K
EX-1.1
STOK
Stoke Therapeutics Inc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded accountability … no material breaches, violations, outages or unauthorized uses of or access to Personal Data, except for those that have been remedied without
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
25 Mar 24
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
4:07pm
PIN to seamlessly access the call. Otherwise please access the listen-only webcast by clicking here. An archived replay of the webcast will be available
SC TO-I/A
EX-99
53kusk5y08vq
17 Nov 23
Issuer tender offer statement (amended)
4:37pm
SC TO-I
EX-99
wsgocgo
2 Nov 23
Issuer tender offer statement
9:01am
SC TO-I
EX-99
aqofpjdb66ho1nm6o
2 Nov 23
Issuer tender offer statement
9:01am
SC TO-I
EX-99
23m6dtmt
2 Nov 23
Issuer tender offer statement
9:01am
SC TO-I
EX-99
f76ool0pcuxp
2 Nov 23
Issuer tender offer statement
9:01am
8-K
EX-99.1
kmlsycf
25 Jul 23
Regulation FD Disclosure
7:05am
PRE 14A
5hngzgirsc1vri qkpd1
17 Apr 23
Preliminary proxy
4:01pm